Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Buffers and Standards
  4. General Chemistry Solutions
  5. 01001927

CERILLIANT™ Rufinamide Solution, 1.0 mg/mL in Acetonitrile:Water (9:1), Sold by MilliporeSigma™ Supelco™

Certified reference material

Supplier:  MilliporeSigma Supelco R0231ML

Catalog No. 01-001-927


Due to product restrictions, please to purchase or view availability for this product.


Description

Description

An antiepileptic drug and anticonvulsant, Rufinamide is approved for the treatment of partial seizures associated with Lennox-Gastaut syndrome in adults and children 4 years and older. Rufinamide is marketed as Banzel™ in the US and Inovelon™ in the EU.
Specifications

Specifications

75-05-8, 106308-44-5
UN 1648 3 / PGII
238.19
1 mL
C10H8F2N4O
1.0 mg/mL in acetonitrile:water (9:1)
Ampule
2°C (35.6°F) - closed cup
Product Suggestions

Product Suggestions

Safety and Handling

Safety and Handling

H332-H319

Recommended Storage : -20°C

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit

CERILLIANT is a registered trademark of Cerilliant Corporation